Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study

por Bello, Natalia, Birt, Julie A., Workman, Jennifer, Zhou, Xian, Ross-Terres, Jorge A., Petri, Michelle
Publicado 2022

Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial

por Dörner, Thomas, van Vollenhoven, Ronald F., Doria, Andrea, Jia, Bochao, Ross Terres, Jorge A., Silk, Maria E., de Bono, Stephanie, Fischer, Peter, Wallace, Daniel J.
Publicado 2022

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

por Dörner, Thomas, Tanaka, Yoshiya, Dow, Ernst R, Koch, Alisa E, Silk, Maria, Ross Terres, Jorge A, Sims, Jonathan T, Sun, Zhe, de la Torre, Inmaculada, Petri, Michelle
Publicado 2022